CN1994449A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN1994449A CN1994449A CNA200610037680XA CN200610037680A CN1994449A CN 1994449 A CN1994449 A CN 1994449A CN A200610037680X A CNA200610037680X A CN A200610037680XA CN 200610037680 A CN200610037680 A CN 200610037680A CN 1994449 A CN1994449 A CN 1994449A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- heart disease
- coronary heart
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 210000003038 endothelium Anatomy 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 239000006187 pill Substances 0.000 claims abstract description 7
- 235000012907 honey Nutrition 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 241000407170 Curcuma Species 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 5
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 244000164439 Curcuma angustifolia Species 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating coronary heart disease. The traditional Chinese medicine is prepared by taking costustoot, white paeony root, ginseng, ligusticum wallichii, dried orange peel, rhizoma cyperi, dutchmanspipe root, salvia miltiorrhiza, poria cocos, radix scrophulariae, hawthorn, endothelium corneum gigeriae galli, angelica sinensis, bighead atractylodes rhizome, radix curcumae and liquorice as raw materials, mixing the raw materials according to a reasonable proportion, and adding a proper amount of honey into the raw materials to prepare a traditional Chinese medicine pill. Has special effect on coronary heart disease. The medicine is warm in nature and easy to take, and has no toxic or side effect. The raw materials are rich in source, the preparation method is simple, and the cost is low.
Description
Technical field
The invention belongs to the Chinese medicine technical field, exactly is a kind of Chinese medicine for the treatment of coronary heart disease.
Technical background
Chronic coronary heart disease is common ailment of middle-aged and old and frequently-occurring disease, course of disease delay, and the symptom complexity, obstinate difficult, recurrence is treated thorny easily.For now, the method for the treatment of chronic coronary heart disease is more, mainly adopts Drug therapy, and mainly is western medicine, but the effect of western medicine coronary heart disease is not really desirable.As Western medicine " hypertension pill " commonly used, total effective rate only 86%, cure rate is just lower.Employing operative treatment coronary heart disease is not only dangerous, expense is huge, patient is painful, and cure rate is lower, and cure rate is 60～70%.How curing this pertinacious disease of chronic coronary heart disease, is countries in the world health organization and the heat subject that relevant scientific research personnel concentrates on studies, and all expects to have medicine evident in efficacy and comes out early, removes the misery of numerous patients with coronary heart disease, brings benefit to the mankind.
Summary of the invention
The object of the present invention is to provide a kind of to treat chronic coronary heart disease good effect, medicine source extensively, the Chinese medicine that has no side effect.
Technical solution of the present invention
Chinese medicine of the present invention is made (consumption is a weight portion) by following component
The Radix Aucklandiae 20～40 Radix Paeoniae Albas 20～40 Radix Ginsengs 10～30
Rhizoma Chuanxiong 30～50 Pericarpium Citri Reticulataes 30～50 Rhizoma Cyperis 20～40
Radix Aristolochiae 20～40 Radix Salviae Miltiorrhizaes 30～50 Poria 10～30
Radix Scrophulariae 10～30 Fructus Crataegis 20～40 Endothelium Corneum Gigeriae Galli 10～30
Radix Angelicae Sinensis 20～40 Rhizoma Atractylodis Macrocephalaes 20～40 Radix Curcumaes 15～35
Radix Glycyrrhizae 10～25.
The production method of above-mentioned each component being made Chinese medicine of the present invention is:
(1) above-mentioned Chinese medicine cleaned respectively, cut into slices, dry, pulverized, grinding, sieving to obtain fine powder;
(2) add by described mixed and make Chinese medicine pill after proper honey stirs.
Effect of the present invention
Because the Radix Aucklandiae, Radix Aristolochiae, Pericarpium Citri Reticulatae, Rhizoma Cyperi are qi-activating drug, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Curcumae can be invigorated blood circulation, the Radix Paeoniae Alba is enriched blood, QI invigorating, analgesic effect, and Radix Ginseng has QI invigorating, blood tonification effect, but Poria diuretic, consumer edema, Radix Scrophulariae has the removing toxic substances and promoting subsidence of swelling effect, Fructus Crataegi can help digestion, removing food stagnancy food blood stasis dispelling blood, and Endothelium Corneum Gigeriae Galli can be good for the stomach, help digestion, goes distension, but Rhizoma Atractylodis Macrocephalae spleen invigorating, QI invigorating, diuretic, Radix Glycyrrhizae has the QI invigorating mediation property of medicine, and therefore this medicine made from these material medicines has the following advantages:
(1) but this medicine stasis and resolving masses disappear, blood flow is unobstructed, thereby makes feeling oppressed that the coronary heart disease human bloodstream freely do not cause, the disease of the nervous cardiopalmus that ischemia causes is eliminated.
(2) the gentle easily clothes of the property of medicine have no side effect.
(3) raw material sources are abundant, and manufacture method is simple, and is with low cost.
The present invention has given sufficient confirmation through to 380 routine patient's clinical treatments so far from 90 years.
Nervous when 40～50 years old patients with coronary heart disease 120 examples, disease are movable, fatigue and weak does not feel like a meal, and the course of disease is 1 month～1 year.Take this Chinese medicine 15 days i.e. course of treatment, one day three ball, every day early, middle and late each once, then eliminate symptom, 120 routine patients all fully recover, and do not see recurrence in 1 year.
51～60 years old patients with coronary heart disease 150 examples, disease be activity or night WA nervous, feel oppressed, breathing heavily does not feel like a meal, the course of disease is 1～3 year.Taking this Chinese medicine 30 days was two courses of treatment, one day three ball, and every day is early, middle evening, respectively once wherein 135 routine patients fully recovered, and 15 routine patients have significant curative effect.
Nervous when 61～70 years old patients with coronary heart disease 110 examples, disease are movable, to feel oppressed, breathing heavily can't be fallen asleep night, and after the paroxysm perspire in the whole body, do not want to eat the disease meal, the lip pastiness, black eye, the course of disease is 1～5 year.Taking this Chinese medicine 45 days was 3 courses of treatment, one day three ball, and every day is early, middle and late respectively once, wherein 95 routine patients' recoveries from illness, 15 routine patients have significant curative effect, and 10 routine patients have certain curative effect.
The clinical data summary sheet
| Age (year) | Case load | Recovery from illness | Significant curative effect | Certain curative effect | |||
| Case load | Cure rate (%) | Case load | Cure rate (%) | Case load | Cure rate (%) | ||
| 30～40 | 120 | 120 | 100 | ||||
| 41～50 | 150 | 135 | 90 | 15 | 10 | ||
| 51～60 | 110 | 95 | 86.4 | 10 | 9 | 5 | 4.6 |
| Add up to | 380 | 350 | 92.1 | 25 | 6.6 | 5 | 1.3 |
The specific embodiment
Embodiment 1
With Radix Aucklandiae 30g, Radix Paeoniae Alba 30g, Radix Ginseng 20g, Rhizoma Chuanxiong 40g, Pericarpium Citri Reticulatae 40g, Rhizoma Cyperi 30g, Radix Aristolochiae 30g, Radix Salviae Miltiorrhizae 40g, Poria 20g, Radix Scrophulariae 20g, Fructus Crataegi 30g, Endothelium Corneum Gigeriae Galli 20g, Radix Angelicae Sinensis 30g, Rhizoma Atractylodis Macrocephalae 30g, Radix Curcumae 25g, Radix Glycyrrhizae 15g cleans respectively, cuts into slices, dries, pulverizes, grinds, its mixing is added proper honey behind the 80 order sieving to obtain fine powders stirs, and makes the heavy Chinese medicine pill of every three money and gets final product.
Embodiment 2
With Radix Aucklandiae 20g, Radix Paeoniae Alba 20g, Radix Ginseng 10g, Rhizoma Chuanxiong 30g, Pericarpium Citri Reticulatae 30g, Rhizoma Cyperi 20g, Radix Aristolochiae 20g, Radix Salviae Miltiorrhizae 30g, Poria 10g, Radix Scrophulariae 10g, Fructus Crataegi 20g, Endothelium Corneum Gigeriae Galli 10g, Radix Angelicae Sinensis 20g, Rhizoma Atractylodis Macrocephalae 20g, Radix Curcumae 15g, Radix Glycyrrhizae 10g cleans respectively, cuts into slices, dries, pulverizes, grinds, its mixing is added proper honey behind the 80 order sieving to obtain fine powders stirs, and makes the heavy Chinese medicine pill of every three money and gets final product.
Embodiment 3
With Radix Aucklandiae 40g, Radix Paeoniae Alba 40g, Radix Ginseng 30g, Rhizoma Chuanxiong 50g, Pericarpium Citri Reticulatae 50g, Rhizoma Cyperi 40g, Radix Aristolochiae 40g, Radix Salviae Miltiorrhizae 50g, Poria 30g, Radix Scrophulariae 30g, Fructus Crataegi 40g, Endothelium Corneum Gigeriae Galli 30g, Radix Angelicae Sinensis 40g, Rhizoma Atractylodis Macrocephalae 40g, Radix Curcumae 35g, Radix Glycyrrhizae 25g cleans respectively, cuts into slices, dries, pulverizes, grinds, its mixing is added proper honey behind the 80 order sieving to obtain fine powders stirs, and makes the heavy Chinese medicine pill of every three money and gets final product.
Claims (3)
1, a kind of Chinese medicine of controlling coronary heart disease is characterized in that being made by following material medicine, and its weight portion is:
The Radix Aucklandiae 20～40 Radix Paeoniae Albas 20～40 Radix Ginsengs 10～30
Rhizoma Chuanxiong 30～50 Pericarpium Citri Reticulataes 30～50 Rhizoma Cyperis 20～40
Radix Aristolochiae 20～40 Radix Salviae Miltiorrhizaes 30～50 Poria 10～30
Radix Scrophulariae 10～30 Fructus Crataegis 20～40 Endothelium Corneum Gigeriae Galli 10～30
Radix Angelicae Sinensis 20～40 Rhizoma Atractylodis Macrocephalaes 20～40 Radix Curcumaes 15～35
Radix Glycyrrhizae 10～25.
2, the Chinese medicine of treatment coronary heart disease according to claim 1 is characterized in that its composition by weight is:
The Radix Aucklandiae 30 Radix Paeoniae Albas 30 Radix Ginsengs 20
Rhizoma Chuanxiong 40 Pericarpium Citri Reticulataes 40 Rhizoma Cyperis 30
Radix Aristolochiae 30 Radix Salviae Miltiorrhizaes 40 Poria 20
Radix Scrophulariae 20 Fructus Crataegis 30 Endothelium Corneum Gigeriae Galli 20
Radix Angelicae Sinensis 30 Rhizoma Atractylodis Macrocephalaes 30 Radix Curcumaes 25
Radix Glycyrrhizae 15.
3, the preparation method of Chinese medicine of treatment coronary heart disease according to claim 1 is characterized in that comprising the steps:
(1) above-mentioned Chinese medicine cleaned respectively, cut into slices, dry, pulverized, grinding, sieving to obtain fine powder;
(2) add by described mixed and make Chinese medicine pill after proper honey stirs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610037680XA CN100423769C (en) | 2006-01-06 | 2006-01-06 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610037680XA CN100423769C (en) | 2006-01-06 | 2006-01-06 | Traditional Chinese medicine for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1994449A true CN1994449A (en) | 2007-07-11 |
| CN100423769C CN100423769C (en) | 2008-10-08 |
Family
ID=38249705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610037680XA Expired - Fee Related CN100423769C (en) | 2006-01-06 | 2006-01-06 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100423769C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102935195A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease as well as preparation method and application thereof |
| CN108324860A (en) * | 2018-04-18 | 2018-07-27 | 高立杨 | A kind of traditional Chinese medicine pill and preparation method thereof for treating coronary heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174075A (en) * | 1997-07-12 | 1998-02-25 | 迟经惠 | Medicine for arteriosclerosis |
| CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
-
2006
- 2006-01-06 CN CNB200610037680XA patent/CN100423769C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102935195A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease as well as preparation method and application thereof |
| CN102935195B (en) * | 2012-12-08 | 2014-03-26 | 王颖翠 | Traditional Chinese medicine composition for treating coronary heart disease as well as preparation method and application thereof |
| CN108324860A (en) * | 2018-04-18 | 2018-07-27 | 高立杨 | A kind of traditional Chinese medicine pill and preparation method thereof for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100423769C (en) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN101670071A (en) | Traditional Chinese medicine preparation for treating cancer and preparation method thereof | |
| CN103536758B (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN102698034A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN100423769C (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN103223079B (en) | Oral administration lipoma treatment traditional Chinese medicine composition and preparation method thereof | |
| CN103520668B (en) | Traditional Chinese medicine for treating heart and qi deficiency symptom type chest stuffiness and pains | |
| CN102698214B (en) | Traditional Chinese medicine for treating migraine and preparation method thereof | |
| CN102688447B (en) | Traditional Chinese medicine for treating palpitation and cardiac pain, and preparation method thereof | |
| CN1097621A (en) | Anti-cancer powder | |
| CN104815118A (en) | Traditional Chinese medicinal composition for treating edema of lower extremity | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN101721479A (en) | Chinese herbal medicine preparation for treating rheumatalgia | |
| CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
| CN105311556A (en) | Traditional Chinese medicine granules for treating jaundice hepatitis and preparation method thereof | |
| CN104274815A (en) | Traditional Chinese medicine composition for treating dysmenorrhea due to deficiency of vital energy and blood | |
| CN103505606A (en) | A kind of Chinese herbal medicine that can grow and black hair | |
| CN105521150A (en) | Preparation method traditional Chinese medicine for reducing blood fat | |
| CN103520352A (en) | Traditional Chinese medicine for treating venation stasis and obstruction symptom type chest stuffiness and pains | |
| CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
| CN102940786A (en) | Traditional Chinese medicine for treating hypertension | |
| CN102698149B (en) | Traditional Chinese medicine for treating chronic headache and preparation method thereof | |
| CN101032613B (en) | Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081008 Termination date: 20110106 |